![]() | ![]() |
Formats:
|
||||||||||||||||
A protein domain-based interactome network for C. elegans early embryogenesis 1Center for Cancer Systems Biology (CCSB) and Department of Cancer Biology, Dana-Farber Cancer Institute, and Department of Genetics, Harvard Medical School, Boston, MA 02115, USA 2Massachusetts General Hospital Cancer Center, Charlestown, MA 02129, USA 3Max Planck Institute of Molecular Cell Biology and Genetics, 01307 Dresden, Germany 4Department of Medical Protein Research, VIB, and Department of Biochemistry, Faculty of Medicine and Health Sciences, Ghent University, 9000 Ghent, Belgium 5Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA 02115, USA 6Center for Genomics & Systems Biology, Department of Biology, New York University, New York, NY 10003, USA 7Computer Science Dept., Stanford University, Stanford, CA 94305, USA 8Division of Developmental Biology, Faculty of Science, Utrecht University, 3584 CH Utrecht, The Netherlands 9Laboratory of Statistical Genetics, The Rockefeller University, 1230 York Avenue, New York, NY 10065, USA 10Center for Computational Biology and Bioinformatics, Indiana University Schools of Medicine and Informatics, 410 W. 10th Street, Indianapolis, IN 46202, USA 11These authors contributed equally to this work. *Correspondence: Email: marc_vidal/at/dfci.harvard.edu (M.V.), Email: hyman/at/mpi-cbg.de (A.A.H.), Email: mboxem/at/partners.org (M.B.) Summary Many protein-protein interactions are mediated through independently folding modular domains. Proteome-wide efforts to model protein-protein interaction or “interactome” networks have largely ignored this modular organization of proteins. We developed an experimental strategy to efficiently identify interaction domains and generated a domain-based interactome network for proteins involved in C. elegans early embryonic cell divisions. Minimal interacting regions were identified for over 200 proteins, providing important information on their domain organization. Furthermore, our approach increased the sensitivity of the two-hybrid system, resulting in a more complete interactome network. This interactome modeling strategy revealed new insights into C. elegans centrosome function and is applicable to other biological processes in this and other organisms. Introduction Physical interactions between proteins are crucial in most biological processes. Hence, there have been major efforts at systematically identifying protein-protein interactions using yeast two-hybrid (Y2H) and affinity pull-down mass spectrometry (AP/MS) approaches (Formstecher et al., 2005; Gavin et al., 2002; Giot et al., 2003; Ho et al., 2002; Ito et al., 2001; Krogan et al., 2006; Li et al., 2004; Rual et al., 2005; Stelzl et al., 2005; Uetz et al., 2000; Walhout et al., 2000). However, such high-throughput assays typically model interactions between full-length proteins, which fails to reflect that most proteins are composed of multiple distinct domains and motifs (Bornberg-Bauer et al., 2005; Liu and Rost, 2004; Pawson and Nash, 2003). Thus, a more precise description of protein-protein interaction networks requires information on the discrete domains that mediate these interactions. Since current knowledge of protein domains is often limited to sequence conservation, new experimental strategies are required to accurately describe large numbers of interaction domains. The Y2H system is ideally suited to identify binary interactions between proteins, and has been used to define interaction domains of individual proteins. However, domain-based Y2H mapping has not been carried out systematically at the scale of a biological process or the whole proteome. We decided to test domain-based interactome mapping on 800 proteins required for C. elegans early embryogenesis, defined as the first two cell divisions following fertilization. C. elegans early embryogenesis is ideally suited for systematic domain-based protein interaction mapping because: (1) most of the proteins involved have been identified (Piano et al., 2002; Sönnichsen et al., 2005; Zipperlen et al., 2001), (2) the proteins are highly conserved in higher eukaryotes, (3) the phenotypic consequences of their inactivation are characterized in detail, and (4) the molecular machines they form have been reasonably well modeled (Gunsalus et al., 2005). Adding domain-based interactome information should bring us closer to the ultimate goal of developing a complete and predictive model of early embryogenesis. Results Domain-based interactome mapping To define interaction domains, we developed a Y2H approach based on screening a PCR-generated library of systematically produced protein domains fused to the Gal4p activation domain (AD-Fragment library) (Figure 1
We first examined the effect of using a fragment library on specificity and detectability of the Y2H system based on a literature derived set of binary interactions between human proteins (Venkatesan et al., personal communication). Specifically, we tested if the AD-Fragment library approach could recover a higher fraction of 20 literature derived interactions than a full-length clone based approach, while retaining specificity, i.e. not identifying interactions between 20 random protein pairs that serve as a negative control. We recovered the 3 literature derived interactions that we previously found to test positive using full-length constructs (Venkatesan et al., personal communication), as well as 4 additional interactions already described in the literature (Figure 1D An early embryogenesis interactome domain map To generate a high quality early embryogenesis AD-Fragment library, we first generated sequence-verified wild-type full-length Gateway (Hartley et al., 2000) entry clones for 681 early embryogenesis proteins (Table S1 and File S1). These clones and an additional 68 full-length PCR products were used as templates in PCR reactions to generate fragments (Figure 1 As bait proteins, we generated 706 full-length Gal4p DNA binding domain (DB) fusion constructs that do not result in auto-activation of Y2H reporter genes (Walhout and Vidal, 2001a) (Table S2). To obtain the highest coverage possible, the AD-Fragment library should ideally be screened with multiple fusions for each bait protein. As this was not feasible for all ORFs, we tested the benefits of using multiple DB-ORF fusion constructs for two molecular machines: the centrosome and the nuclear pore complex (NPC). For 16 centrosome and 12 NPC proteins (Table S2), we generated 5 additional bait constructs corresponding to the N-terminal and C-terminal fragments spanning ~2/3 of the proteins, and the N-terminal, middle, and C-terminal fragments spanning ~1/3 of the proteins. All DB-ORF strains were screened against the AD-Fragment library described above, as well as an AD-cDNA library generated from mixed stage C. elegans (a kind gift from X. Xin and C. Boone, U. Toronto). To increase the precision of our interaction data set, we eliminated de novo autoactivators that arose during the screening process (Vidalain et al., 2004; Walhout and Vidal, 1999), and included only those interactions found in two or more independent yeast colonies. The final data set involves 522 proteins and 755 Y2H interactions between them (Table S3), of which only 92 were previously published or identified by Y2H mapping. Of the 755 interactions, 472 were between early embryogenesis proteins (Figure 2A
Experimental verification of interactions To provide an overall estimate of the quality of our data set, we retested a sample of the identified interactions in an independent assay: the Mammalian Protein-Protein Interaction Trap (MAPPIT) (Eyckerman et al., 2001). MAPPIT is based on reconstitution of a JAK/STAT signaling pathway through interaction of a bait protein fused to a receptor lacking STAT binding sites with a prey protein fused to a STAT recruitment domain. Previously we found that MAPPIT recovers 25% ± 4.7% of 40 literature derived interactions between C. elegans proteins (Figure 2B AD-Fragment library screens increase fraction of detectable interactions Most interactions between early-embryogenesis proteins (376/472) were found only using the AD-Fragment library. This is likely due to a combination of in-depth screening of a normalized library, and detection of interactions that cannot be detected using full-length constructs. The AD-cDNA library derived interactions enabled us to examine the level of saturation of our AD-Fragment library screens, i.e. the fraction of interactions detected out of all interactions that can be identified using the exact Y2H procedure employed here. Out of 96 cDNA derived interactions where both proteins are present in the AD-Fragment library, we recovered 75 (78%) in the AD-Fragment library screens (Figure 2C Most interactions were identified exclusively by AD-ORF clones smaller than the full length ORF (Figure 2D We examined the properties of proteins that were only identified as truncated AD-ORF clones, and found that these proteins are much larger than those for which a full-length clone was observed (average 777 vs. 393 amino acids). We suspect that this is due to larger proteins folding less efficiently in yeast. In addition, although not statistically significant, proteins found as full length were enriched 3.4 fold for the Gene Ontology (GO) term ‘nuclear’, while proteins found only as truncated clones were enriched 4 and 4.6 fold for the GO terms ‘membrane’ and ‘membrane part’ respectively. This fits well with the notion that the Y2H system, which relies on interactions to occur in the nucleus, may have difficulty identifying interactions with membrane proteins. Although the MAPPIT results already demonstrated the overall quality of the data set, we also examined whether certain protein regions taken out of context of the full-length protein may become promiscuous interactors. A promiscuously interacting fragment would result in a prey protein connected to many different bait proteins. Bait proteins were only tested as full-length constructs and would lack such highly connected promiscuous interactors. We therefore compared the distribution of connectivity of bait and prey proteins (Figure 2E An expanded network of early embryogenesis We compared our data set with the most recent version of the worm interactome (CCSB-WI8), which contains 108 interactions between early embryogenesis proteins (http://interactome.dfci.harvard.edu/C_elegans) (Simonis et al. personal communication). Our screens found 45 of these, and identified an additional 427 interactions between early embryogenesis proteins (Figure 2A We used two different criteria to establish the biological relevance of our data set. First, we found that 52 of our interactions were previously identified in C. elegans or as interologs (Matthews et al., 2001; Walhout and Vidal, 2001b) in other organisms (Table S4), as opposed to 4 interactions when the prey names were shuffled. This result supports the overall biological relevance of our interactions. We next compared the Y2H interactions with the RNAi phenotypes of the corresponding genes. Detailed phenotypic characterizations are available from RNAi experiments for most of the genes involved in early embryogenesis (Sönnichsen et al., 2005). Out of 320 interactions where a phenotypic profile was determined for both binding partners, 55 (17%) belonged to the same functional class (Figure 3A
Finally, we examined whether interactions identified only by truncated clones are as biologically relevant as interactions where a full-length clone was identified. We therefore compared the enrichment in shared GO terms, phenotypes, and expression profiles between these subsets of interactions (Figure S2). We restricted the analysis of interactions where only truncated clones were identified to those interactions where a full-length clone was >50% likely to have been identified. Although the numbers that can be examined are low and there were variations, no significant differences were found between the two sets. Therefore, interactions where only truncated AD-ORF clones were found are not dramatically less biologically relevant by these criteria. Centrosome assembly and nuclear pore complex architecture We used our domain-based interaction data set to examine interactions within two different molecular machines: the nuclear pore complex (NPC) and the centrosomes. The first is a symmetric molecular array whose structure has been solved at high resolution using conventional methods, whereas centrosomes, apart from the centriole, have no apparent ultrastructural organization. We first examined the results of using multiple DB-ORF fusion constructs for each bait protein. In the entire screen, 37% of full-length DB-ORF fusions yielded interactors. The use of 5 additional bait constructs for 28 centrosome and nuclear pore proteins resulted in the identification of interactors for 23 of these 8 proteins (82%), illustrating that greater coverage can be obtained by using multiple constructs for each bait protein. Current understanding of NPC architecture is summarized in Figure 4A
Figure 4B We recovered 12 interactions between proteins throughout the centrosome assembly pathway, indicating that this process can be viewed as a set of binary protein-protein interactions that can occur independently of one another. We identified all four previously described direct physical interactions (SAS-5/SAS-6, SPD-5/RSA-2, AIR-1/TPXL-1, and TAC-1/ZYG-9). The remaining intra-centrosomal interactions are novel physical interactions consistent with previous epistatic analyses. The homotypic interactions of SAS-5 and SPD-5 suggest a scaffolding role for these proteins in centriole duplication and PCM assembly, respectively. The binding of both SPD-2 and AIR-1 (the aurora A homolog in C. elegans) to SPD-5 provides a testable biochemical model for the genetic requirement of all three proteins for PCM growth. Moreover, both SAS-4 and SPD-2 are required for centriole duplication and bind PLK-1. As SPD-2 is required to target PLK-1 to the centrioles, the role of SPD-2 in centriole duplication might in part be the targeting of PLK-1 to SAS-4. We also identified two novel interactors of RSA-2: the microtubule-associated proteins TAG-201 and EBP-1. TAG-201 is uncharacterized, while EBP-1 is an evolutionarily conserved protein that binds the growing plus-ends of microtubules. Functional analysis of RSA-2 binding to the microtubule-binding proteins should shed light on how PP2A stabilizes microtubules in mitosis. Identification and validation of minimal regions of interaction For each interaction, we defined the minimal region of interaction (MRI) as the smallest region shared by all interacting protein fragments. Our approach was sensitive enough to resolve two independent Ran-binding domains in NPP-9 (Figure 5A
To verify the accuracy of the identified MRIs, we first compared them to published interaction domains. For 26 proteins in our data set, interaction domains were present in the literature. For 23 (88%), the MRI identified is consistent with the known interaction site of the C. elegans or orthologous protein, demonstrating the accuracy of our approach (Table S4). For three, we found a difference between our MRI and the interaction site of the orthologous human proteins (Figure 6A
To experimentally demonstrate the functional relevance of novel MRIs, we examined the subcellular localization of SAS-5 and RSA-2 MRIs by fusing them to GFP. SAS-5 localizes to centrioles in a SAS-6 dependent manner, while RSA-2 localizes to the PCM in a SPD-5 dependent manner. We generated transgenic lines expressing GFP fusions of the SAS-5 and RSA-2 MRIs responsible for binding to SAS-6 and SPD-5 respectively. The RSA-2 and SAS-5 MRIs accurately recapitulated the localization of the full-length proteins to the PCM and centrioles, respectively (Figure 6B Comparison of MRIs with computational predictions Although protein interactions have traditionally been viewed as being between two structured domains, many interactions involve one structured domain and a short, linear amino acid motif (Davey et al., 2006; Puntervoll et al., 2003) typically present in a disordered loop or tail (Fuxreiter et al., 2007; Mohan et al., 2006). To better understand the structural composition of the MRIs delineated, we examined them for overlap with computational domain and structure predictions (Table S5). The predictors used were: Pfam-A and Superfamily, two collections of manually curated domain signatures (Finn et al., 2008; Gough et al., 2001); Pfam-B, a collection of automatically generated domain signatures (Finn et al., 2008); Ginzu, a protocol using orthologous protein sequences to predict the boundaries of globular domains (Chivian et al., 2003); COILS, a coiled-coil prediction algorithm (Lupas et al., 1991); and two different predictors of disordered regions: PONDR VL-XT (Li et al., 1999; Romero et al., 2001) and VSL2 (Obradovic et al., 2005; Peng et al., 2006). We did not observe enrichment of any domain predictions in MRIs compared to the whole proteins (Figure 6C We used the overlap between MRIs and the domain predictions to classify our MRIs as known folding region (Pfam-A, Superfamily, structure-based Ginzu), predicted folding region (Pfam-B, coiledcoil, non-structure-based Ginzu), unstructured region (>50% of residues predicted to be disordered), or potential new folding region. As minimal overlap cutoffs for classifying an MRI we used 20%, 40%, 60%, or 80% of the MRI length. Depending on the cutoff chosen, the fraction of novel folding and disordered MRIs ranges from 14% to 38% (Figure 6D Finally, we compared our experimentally defined MRIs with binding sites predicted by InSite, a recently developed algorithm that predicts protein-protein interaction binding sites based on the domain composition of proteins (Wang et al., 2007). We used InSite to predict Pfam-A binding sites for those interactions where the MRI overlaps with a single Pfam-A domain, and the protein contains more than one Pfam-A domain. For 78 interactions satisfying these criteria, 53 binding site predictions (68%) matched our experimentally defined MRI. Randomly assigning a Pfam-A domain as binding site for each interaction results in a 35% overlap with our MRIs. The high overlap between binding site predictions and experimentally defined MRIs further highlights the quality of our approach. Discussion The use of an AD-Fragment library provides a way to rapidly map interacting regions in proteins and results in a significant increase in sensitivity of the Y2H system. Randomly generated fragment libraries have already been used to map protein interactions of yeast and Plasmodium falciparum (Fromont-Racine et al., 1997; Guglielmi et al., 2004; LaCount et al., 2005). For yeast, the library was generated by randomly fragmenting genomic DNA, an approach that is not applicable to higher eukaryotes as only a small fraction of DNA is coding and most genes contain introns. For Plasmodium, the library was generated from cDNA. This approach is applicable to higher eukaryotes, but would suffer from variable representation of different gene products and the presence of 5' and 3' untranslated regions. By starting from full-length ORF clones and using PCR to generate the fragments, we created a nearly normalized library in which each ORF is systematically represented be multiple fragments of different sizes. To our knowledge, our protein domain data set represents the largest effort to date to experimentally identify protein interaction domains for a higher eukaryote. The MRIs that we identified provide structural information for many early embryogenesis proteins. We expect that the MRIs identified can serve as a foundation for future studies, such as high-resolution structural analysis of these protein interactions in vitro, or the targeting of individual interactions for disruption. Although the use of an AD-Fragment library alone provided a dramatic increase in knowledge of the protein interactions underlying C. elegans early embryogenesis, even greater coverage can be obtained by using multiple bait constructs. The AD-Fragment library will be made available upon request, and can be used by others interested in increasing understanding of early embryogenesis. Experimental procedures Generating wild-type entry clones To generate wild-type entry clones, predicted ORFs for each early embryogenesis gene were PCR-amplified from a mixed stage C. elegans cDNA library, and Gateway cloned into entry vector pDonr223. For each ORF, we sequenced up to 6 individual clones. An entry clone was considered wild-type if it contained no mutations or only silent changes within the open reading frame. AD-Fragment library generation Forward and reverse primers with AscI and NotI tails were designed at specific distance intervals across each ORF (75 – 198 base pairs (bp), see Figure 1 Generating Y8930 bait strains Full-length sequence verified ORFs were transferred to pDest-pPC97 in a Gateway LR reaction. In addition, we cloned 41 full-length ORFs for which no wild-type clone was obtained but a PCR fragment of the right size was generated. Centrosome and NPC Fragment baits were cloned using gap repair. PCR fragments generated during AD-Fragment library creation were further elongated using primers that anneal to the existing AscI and NotI tails. PCR products were transformed into yeast strain Y8930, together with linearized pPC97-AN (a modified version of pPC97 that contains AscI and NotI sites inframe with the DB sequence). All bait strains were plated on Sc –Leu –His plates to eliminate baits able to activate reporter genes in the absence of AD plasmid (auto-activators). Library screening Y2H library screens were done using a mating approach (Fromont-Racine et al., 2002). A total of ~6 × 107 cells of bait yeast and prey library yeast were mixed in equal proportions, and allowed to mate on YEPD for 4 hours before plating on a 15 cm ø Sc –Leu –Trp –His plate. After 4 days of growth at 30°C, colonies were picked for sequence analysis and de novo autoactivators were eliminated as described (Vidalain et al., 2004). Phenotypic comparison Phenotype correlations between gene pairs range from 0 – 1 (Gunsalus et al., 2005). Fold enrichments were calculated for 4 correlation ranges: 0 – 0.25, 0.25 – 0.5, 0.5 – 0.75, and 0.75 – 1.0. The fold enrichment is the fraction of protein pairs in the interaction network that share a phenotype correlation, relative to the average correlation between all possible pairs of the proteins in the observed interaction network. Significance was calculated using Fisher’s exact test. GO term analysis Gene Ontology (GO) functional annotations were obtained from the GO database (March 2008 http://www.geneontology.org/). To identify GO terms enriched in one set of proteins, we used Funcassociate (http://llama.med.harvard.edu/cgi/func/funcassociate). To calculate GO term enrichment in protein interactions we used in-house scripts using the R software (http://www.r-project.org). Fisher’s exact test was used to calculate significance. Gene expression profiling comparison Microarray data from 378 experimental conditions were obtained from WormBase (Table S5). For each pair of genes, the pair-wise Pearson Correlation Coefficient (PCC) was calculated using the R software (http://www.r-project.org), taking into account only the experimental conditions defined for the two genes. AD-Fragment analysis of human literature derived protein pairs For the 80 proteins (40 protein pairs), an AD-Fragment library was generated and screened using full-length proteins as described above for C. elegans proteins. Retest by MAPPIT MAPPIT was performed as described (Eyckerman et al., 2001). Each protein pair is tested in both configurations (bait-prey and prey-bait) and in two independent trials, for a total of four trials. An interaction was scored as positive if at least two of the four trials scored positive. Generation of GFP-fusion constructs and transgenic lines Full length rsa-2 was cloned into vector TH304 (Green et al., 2008) (C-terminal GFP fusion), rsa-2 nucleotides 583 – 1326 was cloned into vector TH315 (Green et al., 2008) (N-terminal S-peptide/GFP fusion), full-length sas-5 and sas-5 nucleotides 586 – 1212 were cloned into vectors GFPLAP Gateway (Nterminal S-peptide/GFP fusion) and the newly generated pDest-MB16 (C-terminal GFP fusion). Transgenic lines were generated by microparticle bombardment (Praitis et al., 2001). For SAS-5, the best expressing constructs were selected for imaging. Comparing MRIs to computational predictions Pfam-A and Superfamily predictions used scripts available from ftp://ftp.sanger.ac.uk/ and http://www.ebi.ac.uk/interpro/. Coiled-coil and disorder predictions by PONDR VL-XT and VSL2 were performed as described (Li et al., 1999; Lupas et al., 1991; Obradovic et al., 2005; Peng et al., 2006; Romero et al., 2001). Pfam-B predictions used the HMMER2 package (http://hmmer.janelia.org/). Ginzu implements a hierarchically organized combination of sequence based methods (primarily PSI-BLAST, FFAS03 and Pfam) to separate proteins into domains. For comparisons of MRIs to domain predictors, we treated duplicate MRIs with identical start and stops as a single MRI. InSite predictions were performed as previously described (Wang et al., 2007) using 4,542 Y2H interactions and the Pfam-A and Pfam-B domain content of the associated proteins as input. Classifying MRIs by structure We first searched for MRIs that share more than a certain fraction of residues (20%, 40%, 60%, or 80%) with Pfam-A domains, Superfamily domains, or Ginzu domains with pdbblast or ffas03 evidence. An MRI matching these domains is classified as ‘Known folding region.’ The remaining MRIs were examined for overlap with Pfam-B, coiled-coil, or Ginzu domain predictions not based on pdb or ffas03 at the same cutoff levels for classification as ‘Predicted folding region.’ The remaining MRIs were split into Unstructured (>50% of amino acids predicted to be disordered) or Novel folding region. Data availability The website http://interactome.dfci.harvard.edu/fragdb/ provides a searchable interface with details on interacting fragments and domain predictions for all C. elegans Y2H interactions for which such information is available. Interactions have also been submitted to the IMEx consortium (ID: MINT-660970) and can be accessed at http://mint.bio.uniroma2.it/mint/search/interaction.do?interactionAc=MINT-6606970. 01: Supplemental Data Supplemental Data include supplemental experimental procedures, five figures, six tables, and one Fasta file, and can be found with this article online. Click here to view.(3.7M, pdf) 02: Document S1. Fasta file with complete sequences of the wild-type entry clones we generated All sequences correspond to actual sequencing data. Capitalized bases are deviations from ORF predictions in Wormbase release WS150. Additional details are available in Table S1, sheet 4. Click here to view.(989K, txt) 03: Table S1. List of early embryogenesis genes included and details of wild-type cloning efforts Click here to view.(290K, xls) 04: Table S2. Details of the ORFs and fragments included in the AD-Fragment library and details of the DBORF fusions used as baits Click here to view.(222K, xls) 05: Table S3. Details of all interactions identified, including minimal regions of interaction Click here to view.(642K, xls) 06: Table S4. Comparisons of identified interactions and minimal regions of interaction with previously published data Click here to view.(89K, xls) 07: Table S5. Comparisons of minimal regions of interaction with computationally predicted domains and disordered regions Click here to view.(226K, xls) 08: Table S6. List of expression profiling papers contained in Wormbase compendium shown in Figure 3 Click here to view.(35K, xls) Acknowledgements We are grateful to X. Xin and C. Boone for sharing of the cDNA library and yeast strains, to Joe Hargitai for unparalleled parallel computing support, to IBM’s World Community Grid (http://www.wcgrid.org), and to M. Cusick for critical reading of the manuscript. Support was provided by the Leukemia Research Foundation to M.B., the W.M. Keck foundation to M.V., the FWO-V to I.L., NIH grants R21RR023114 (M.B. P.I.), R01HG001715 (M.V. P.I.), R33CA105405 (M.V. P.I.), CA81658 (M.V. P.I.), R21CA113711 (L.M.I. P.I.), U54 CA011295 (J. Nevins, PI; M.V. sub-contract), and CA95281 (S.v.d.H.), US Army Medical Research Acquisition Activity grant W23RYX-3275-N605 (K.C.G.), NYSTAR grant C040066 (K.C.G.), NSF grants MCB 0444818 to L.M.I. and BDI-0345474 to D.K., and grants IUAP-P6:28, UG-GOA12051401 and FWO-G.0031.06 to J.T‥ Footnotes Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final citable form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain. References
|
PubMed related articles
Your browsing activity is empty. Activity recording is turned off. |
|||||||||||||||
Genome Res. 2005 Mar; 15(3):376-84.
[Genome Res. 2005]Nature. 2002 Jan 10; 415(6868):141-7.
[Nature. 2002]Science. 2003 Dec 5; 302(5651):1727-36.
[Science. 2003]Nature. 2002 Jan 10; 415(6868):180-3.
[Nature. 2002]Proc Natl Acad Sci U S A. 2001 Apr 10; 98(8):4569-74.
[Proc Natl Acad Sci U S A. 2001]Curr Biol. 2002 Nov 19; 12(22):1959-64.
[Curr Biol. 2002]Nature. 2005 Mar 24; 434(7032):462-9.
[Nature. 2005]EMBO J. 2001 Aug 1; 20(15):3984-92.
[EMBO J. 2001]Nature. 2005 Aug 11; 436(7052):861-5.
[Nature. 2005]Nat Genet. 2003 May; 34(1):35-41.
[Nat Genet. 2003]Genome Res. 2000 Nov; 10(11):1788-95.
[Genome Res. 2000]Curr Opin Struct Biol. 2003 Feb; 13(1):110-4.
[Curr Opin Struct Biol. 2003]Methods. 2001 Jul; 24(3):297-306.
[Methods. 2001]Methods. 2004 Apr; 32(4):363-70.
[Methods. 2004]Genome Res. 1999 Nov; 9(11):1128-34.
[Genome Res. 1999]Nat Cell Biol. 2001 Dec; 3(12):1114-9.
[Nat Cell Biol. 2001]Genome Res. 2001 Dec; 11(12):2120-6.
[Genome Res. 2001]Nat Rev Mol Cell Biol. 2001 Jan; 2(1):55-62.
[Nat Rev Mol Cell Biol. 2001]Nature. 2005 Mar 24; 434(7032):462-9.
[Nature. 2005]Nature. 2005 Aug 11; 436(7052):861-5.
[Nature. 2005]Nature. 2007 Nov 29; 450(7170):695-701.
[Nature. 2007]Curr Opin Cell Biol. 2006 Jun; 18(3):342-7.
[Curr Opin Cell Biol. 2006]Curr Opin Struct Biol. 2005 Apr; 15(2):221-6.
[Curr Opin Struct Biol. 2005]Mol Biol Cell. 2003 Dec; 14(12):5104-15.
[Mol Biol Cell. 2003]WormBook. 2006 Jan 19; ():1-40.
[WormBook. 2006]J Cell Biol. 2008 Feb 25; 180(4):771-85.
[J Cell Biol. 2008]Curr Biol. 2006 Sep 19; 16(18):1844-9.
[Curr Biol. 2006]Nature. 2006 Nov 30; 444(7119):619-23.
[Nature. 2006]Dev Cell. 2004 Apr; 6(4):511-23.
[Dev Cell. 2004]J Biol Chem. 1999 Dec 24; 274(52):37370-8.
[J Biol Chem. 1999]Nucleic Acids Res. 2006; 34(12):3546-54.
[Nucleic Acids Res. 2006]Nucleic Acids Res. 2003 Jul 1; 31(13):3625-30.
[Nucleic Acids Res. 2003]Bioinformatics. 2007 Apr 15; 23(8):950-6.
[Bioinformatics. 2007]J Mol Biol. 2006 Oct 6; 362(5):1043-59.
[J Mol Biol. 2006]Nucleic Acids Res. 2008 Jan; 36(Database issue):D281-8.
[Nucleic Acids Res. 2008]Genome Biol. 2007; 8(9):R192.
[Genome Biol. 2007]Nat Genet. 1997 Jul; 16(3):277-82.
[Nat Genet. 1997]Nucleic Acids Res. 2004; 32(18):5379-91.
[Nucleic Acids Res. 2004]Nature. 2005 Nov 3; 438(7064):103-7.
[Nature. 2005]Methods Enzymol. 2002; 350():513-24.
[Methods Enzymol. 2002]Methods. 2004 Apr; 32(4):363-70.
[Methods. 2004]Nature. 2005 Aug 11; 436(7052):861-5.
[Nature. 2005]Nat Cell Biol. 2001 Dec; 3(12):1114-9.
[Nat Cell Biol. 2001]Methods Cell Biol. 2008; 85():179-218.
[Methods Cell Biol. 2008]Genetics. 2001 Mar; 157(3):1217-26.
[Genetics. 2001]Genome Inform Ser Workshop Genome Inform. 1999; 10():30-40.
[Genome Inform Ser Workshop Genome Inform. 1999]BMC Bioinformatics. 2006 Apr 17; 7():208.
[BMC Bioinformatics. 2006]Proteins. 2001 Jan 1; 42(1):38-48.
[Proteins. 2001]Genome Biol. 2007; 8(9):R192.
[Genome Biol. 2007]